Conformal Medical Closes $35M Series D Financing
Conformal Medical’s proprietary CLAAS technology features a foam-based architecture designed to conform to a broad range of LAA anatomies with only two sizes.
Read MoreConformal Medical’s proprietary CLAAS technology features a foam-based architecture designed to conform to a broad range of LAA anatomies with only two sizes.
Read Morewhich will be used for clinical trials of its digestive endoscopic surgical robot products and research and development of new products
Read Morea Paris-based medical technology company developing unique artificial intelligence software focused on improving the detection of congenital heart defects in fetuses
Read MoreThe new proceeds will support increased adoption of its product suite, establishment of global partnerships, and the expansion of RedDress’ proprietary blood-based technology to treat more conditions
Read MoreMoon Surgical is creating an entirely new category of Robotic Surgery with its Maestro System, one that not only changes the scale at which robotics are used but also improves the bottom line for providers and the quality of care for patients.
Read Morethe Series B funds will be used for Clinical Trials of Epilepsy Neuromodulation Therapy
Read MoreSealonix is using its biomaterials expertise to develop next generation hemostatic sealants for surgical use
Read MoreSensydia continues to push the boundaries of AI in heart function assessment
Read MoreInvestment will fuel adoption of the company’s signature OR Black Box® technology, which is already used by leading academic healthcare centers across North America and Europe
Read MoreThe investment is set to accelerate U.S. adoption of its smartphone-powered kidney test following a landmark FDA clearance, enabling 75 million Americans at risk of chronic kidney disease to test at-home
Read More